AGs Announce $335M Opioid Deal With Mylan

By Emily Field

New York Attorney General Letitia James on Monday said her office and those of other states reached a $335 million deal with Mylan to help combat the opioid crisis.

Read full article » | Save to favorites »

Analysis

Ruling Adds To Risk Of Patent Format Tied To Improvements

By Ryan Davis

A Federal Circuit decision from last month has created pitfalls for entities using a type of patent claim that describes an improvement on previous technology, making the so-called Jepson format, which is already uncommon, even less appealing for applicants, attorneys said.

Opinion attached | Read full article » | Save to favorites »

Birth Control Companies Escape Conn. Long-Arm Injury Suits

By Jonathan Capriel

Eight women who claim to have suffered severe and debilitating injuries after a birth control device — the Filshie Clip — implanted in their body migrated cannot sue in Connecticut state court the companies that designed, manufactured and distributed the clip, a judge has ruled, saying he doesn't have jurisdiction over the out-of-state companies.

2 documents attached | Read full article » | Save to favorites »

Policy Group Tells 4th Circ. Drug Discount Law Needs Reform

By Hayley Fowler

The Fourth Circuit on Monday allowed a Boston-based think tank to file an amicus brief supporting a district court's injunction against a West Virginia law that pharmaceutical companies and lobbyists claim unconstitutionally expands a federal drug discount program.

3 documents attached | Read full article » | Save to favorites »

Incyte Can't Get Pretrial Win In Novartis Royalty Fight

By Adam Lidgett

A New York federal judge has disagreed with Incyte Corp.'s argument that its interpretation of a drug commercialization contract at the heart of a royalties dispute with Novartis Pharma AG is the right one, ahead of a jury trial scheduled next month.

Order attached | Read full article » | Save to favorites »

Drug Buyers, Generics Cos. Fight Over Bellwether Litigation

By Bryan Koenig

Generic drug buyers vied Friday with the pharmaceutical companies they've accused of price-fixing over how to shape the first rounds of long-gestating Pennsylvania federal court litigation that the plaintiffs want heard in separate consecutive trials and that the drugmakers want combined.

2 documents attached | Read full article » | Save to favorites »

Torrent Seeks Arbitration In Drug Commercialization Fight

By Caroline Simson

A subsidiary of Indian multinational company Torrent Pharmaceuticals is urging a Delaware judge to force OWP Pharmaceuticals to arbitrate a dispute over issues that allegedly delayed the U.S. commercialization of its epilepsy and anti-seizure medications.

Brief attached | Read full article » | Save to favorites »

Monthly Merger Review Snapshot

By Matthew Perlman

The Federal Trade Commission sued to block GTCR BC's planned purchase of a medical device coatings company, the Justice Department's antitrust case against Live Nation survived a dismissal bid and a New York state court found a ski mountain deal hurt competition. Here, Law360 looks at the major merger review developments from March.

Read full article » | Save to favorites »

Compensation Up For Quest Diagnostics GC After Earlier Dip

By Jake Maher

Quest Diagnostics' longtime senior vice president and general counsel brought home $2.43 million in 2024, up from $2.25 million in 2023, according to a proxy statement filed recently by the company.

Read full article » | Save to favorites »

A Higher Bar For Expert Witnesses In Drug Patent Litigation

With recent decisions emphasizing courts' growing insistence on robust methodologies in pharmaceutical patent disputes, litigators must be strategic in how they utilize expert testimony and adapt to venue-specific expectations, says Jeremy Scholem at WIT Legal.

Read full article » | Save to favorites »

Series

Law School's Missed Lessons: Be An Indispensable Associate

While law school teaches you to research, write and think critically, it often overlooks the professional skills you will need to make yourself an essential team player when transitioning from a summer to full-time associate, say attorneys at Stinson.

Read full article » | Save to favorites »

Trump Wants To Use Firms That Cut Deals For Coal Leases

By Keith Goldberg

President Donald Trump said Tuesday that he wants to help coal companies with their leasing matters by proffering the services of BigLaw firms that signed agreements to avoid getting shut out of government work.

Read full article » | Save to favorites »

Clifford Chance Lands Gibson Dunn Restructuring Co-Chair

By Tracey Read

Clifford Chance LLP announced Tuesday that it has hired the former co-chair of Gibson Dunn & Crutcher LLP's corporate restructuring practice to co-lead its global restructuring and insolvency practice.

Read full article » | Save to favorites »

DOJ Shuts Crypto Unit, Shifts Focus From Intermediaries

By Aislinn Keely

The U.S. Department of Justice is disbanding its crypto unit and directing prosecutors to focus on cases against individuals who harm crypto investors or use digital assets to further other illegal activity, instead of bringing cases against platforms that enable the conduct, according to a memo circulated to all department employees.

Memorandum attached | Read full article » | Save to favorites »

Atty Says Debevoise Fired Him Over Medical Leave

By Emmy Freedman

Debevoise & Plimpton LLP fired an attorney in its international dispute resolution practice group because he had taken medical leave, abruptly dismissing him two days after he returned, and refused to give him a chance to increase his billable hours, he told a New York federal court.

Complaint attached | Read full article » | Save to favorites »

In Trump Order Against Perkins Coie, GCs See Harm For Cos.

By Jake Maher

Nearly 70 current and former general counsel for companies including Apple Inc. and Starbucks filed an amicus brief Tuesday supporting Perkins Coie LLP in its suit against an executive order from President Donald Trump targeting the firm, saying the order "tramples on corporate independence, the right to counsel, and First Amendment rights."

2 documents attached | Read full article » | Save to favorites »

Ballard Spahr Fired Atty For Taking Medical Leave, Suit Says

By Patrick Hoff

A former attorney for Ballard Spahr LLP filed suit against the firm and the head of its employee benefits group Tuesday in New York federal court, claiming she was fired for taking medical leave and seeking a more flexible work schedule to deal with her epilepsy and a gastrointestinal condition. 

Complaint attached | Read full article » | Save to favorites »

Cravath Private Equity Co-Leader Joins Sidley In New York

By Andrea Keckley

Sidley Austin LLP announced Tuesday that the former co-head of Cravath Swaine & Moore LLP's private equity group is the latest addition to its growing mergers and acquisitions and private equity bench.

Read full article » | Save to favorites »